- Combined Assessment of Serum Alpha-Synuclein and Rab35 is a Better Biomarker for Parkinson's Disease
-
Wang HL, Lu CS, Yeh TH, Shen YM, Weng YH, Huang YZ, Chen RS, Liu YC, Cheng YC, Chang HC, Chen YL, Chen YJ, Lin YW, Hsu CC, Lin HL, Chiu CH, Chiu CC
- KMID: 2467758
- J Clin Neurol.
- 2019 Oct;15(4):488-495.
- doi: 10.3988/jcn.2019.15.4.488
BACKGROUND AND PURPOSE: It is essential to develop a reliable predictive serum biomarker for Parkinson's disease (PD). The accumulation of alpha-synuclein (αSyn) and up-regulated expression of Rab35 participate in the... -
- CITED
-
- Close
- SHARE
-
- Close
- Trough Melatonin Levels Differ between Early and Late Phases of Alzheimer Disease
-
Lin CH, Chiu CC, Lane HY
- KMID: 2513399
- Clin Psychopharmacol Neurosci.
- 2021 Feb;19(1):135-144.
- doi: 10.9758/cpn.2021.19.1.135
Objective: Melatonin has been considered to have an essential role in the pathophysiology of Alzheimer’s disease (AD) for its regulatory function on circadian rhythm and interaction with glutamate for the... -
- CITED
-
- Close
- SHARE
-
- Close
